The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy

Grants

Funding Acknowledgements

We would like to acknowledge the consumers involved in the Walter and Eliza Hall Institute Buddy Program who have contributed to this review: Mr George Kiossoglou and Ms Elizabeth Flemming-Judge have provided valuable advice and insight. We would also like to thank the Walter and Eliza Hall Institute graphics department, in particular Mr Peter Maltezos, for his assistance with preparing figures. Results published here are, in part, based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.Authors are supported by project grants from the National Health and Medical Research Council (NHMRC) of Australia (#1124784, #1066770, #1057852, #1124907 to N.D.H; and #1140406 to F.S.F.G). F.S.F.G. was supported by a NHMRC Early Career Fellowship (1088703), a National Breast Cancer Foundation (NBCF) Fellowship (PF-15-008), a grant #1120725 awarded through the Priority-driven Collaborative Cancer Research Scheme and funded by Cure Cancer Australia with the assistance of Cancer Australia. N.D.H is a NHMRC CDF2 Fellow (1124788), a recipient of a Melanoma Research Grant from the Harry J. Lloyd Charitable Trust, Melanoma Research Alliance Young Investigator Award, and a CLIP grant from Cancer Research Institute. This study was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support scheme.